home / stock / bway / bway news


BWAY News and Press, BrainsWay Ltd. From 01/31/22

Stock Information

Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com

Menu

BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...

BWAY - BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS(TM) for the Treatment of OCD

BURLINGTON, Mass. and JERUSALEM, Jan. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that a fin...

BWAY - BrainsWay Announces Addition of Markus Heilig, M.D., Ph.D., to Scientific Advisory Board

BURLINGTON, Mass. and JERUSALEM, Jan. 26, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the addition of Professor Markus ...

BWAY - BrainsWay Announces Multiple Publications of New Real-World OCD Data for its Deep TMS(TM) System

BURLINGTON, Mass. and JERUSALEM, Israel, Jan. 12, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced ke...

BWAY - BrainsWay Announces Publication of Deep TMS(TM) Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects

Randomized, Placebo-Controlled, Double-Blind Pilot Study Evaluated Deep TMS Treatment in Reducing Alcohol Consumption and Craving for Adults with Alcohol Use Disorder Study Findings to be Featured Today at Brain Stimulation Conference Symposium BURLINGTON, Mass. and JE...

BWAY - BrainsWay to Present at the Sidoti December Micro-Cap Investor Conference

BURLINGTON, Mass. and JERUSALEM, Nov. 30, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Chris...

BWAY - BrainsWay Ltd. (BWAY) CEO Christopher von Jako on Q3 2021 Results - Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q3 2021 Earnings Conference Call November 17, 2021 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors, IR Christopher von Jako - President and CEO Scott Areglado - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Destiny Hance ...

BWAY - BrainsWay Ltd. 2021 Q3 - Results - Earnings Call Presentation

The following slide deck was published by BrainsWay Ltd. in conjunction with their 2021 Q3 earnings call. For further details see: BrainsWay Ltd. 2021 Q3 - Results - Earnings Call Presentation

BWAY - BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights

Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System for Treatment of Anxious Depression Conference Call to be held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2021 (GLOBE NEWSWIRE) -- BrainsWay...

BWAY - Sidoti Microcap Virtual Conference

A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti & Company, LLC has updated its preliminary list of presenting companie...

BWAY - BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021

BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it wi...

Previous 10 Next 10